BridgeBio Pharma

+$0.35 (+0.71%) Today
$0.00 (0.00%) As of 8:01 AM UTC after-hours

Why Robinhood?

You can buy or sell BBIO and other stocks, options, and ETFs commission-free!

About BBIO

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development.

CEO
Neil Kumar
Employees
385
Headquarters
Palo Alto, California
Founded
2015

BBIO Key Statistics

Market Cap
7.22B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
853.61K
High Today
$51.28
Low Today
$48.42
Open Price
$48.53
Volume
867.37K
52 Week High
$73.50
52 Week Low
$26.17

BBIO Earnings

-$1.18
-$0.79
-$0.39
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.80 per share
Actual
-$1.18 per share

You May Also Like

OPTN
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure